Recent news on Norvasc

Apotex says launches generic of Pfizer's Norvasc  -  25 May 2007
ReutersNorvasc had been one of Pfizer's biggest selling products. But Mylan Laboratories Inc. (MYL.N: Quote, Profile, Research began selling its generic version in

Pfizer's Petition for Rehearing in Norvasc Case Denied  -  May 22, 2007
Seeking Alpha,The FDA announced last month that it would grant final approval to Apotex's ANDA for generic Norvasc when the Federal Circuit issues a mandate in Pfizer v.

US Appeals Court Won't Rehear Norvasc Patent Ruling  -  May 21, 2007
Reuters.uk,...a decision favoring Canadian drugmaker Apotex Inc. in its efforts to launch a generic form of Pfizer's blockbuster blood-pressure drug, Norvasc.

Roxas: Scrap Norvasc patent  -  May 12, 2007
Manila Times,Mar Roxas said scrapping the patent of hypertension drug Norvasc in the Philippines could benefit 7.7 million Filipinos with hypertension.

Exforge® Helps Vast Majority Of Patients Effectively Control Their ...  -  May 21, 2007
Medical News Today (press release),Norvasc Web site. http://www.norvasc.com/high-blood-pressure-medicine/about-norvasc.asp?print=true. Accessed November 28, 2006.

Philippines files petition to cancel Pfizer's patent on ...  -  May 8, 2007
International Herald Tribune,MANILA, Philippines: A petition was filed Tuesday to cancel Pfizer's Philippine patent on the anti-hypertension drug Norvasc after a US court invalidated

FDA Decision on Pfizer's Norvasc Exclusivity Upheld  -  May 2, 2007
Seeking Alpha,Aaron F. Barkoff submits: In an April 18 decision, the FDA determined that Pfizer (PFE) is entitled to six months of pediatric exclusivity on Norvasc

Pfizer loses appeal to revive patent  -  May 22, 2007
Los Angeles Times,Pfizer Inc. lost an appeals court bid to revive its patent on the hypertension drug Norvasc, a ruling that opened the door to generic competition.

Pfizer Research Head To Retire, CFO to Resign  -  May 21, 2007
St Petersburg Times, Russia,Revenue this year will be $1.2 billion less than Pfizer projected after an adverse court ruling accelerated generic competition to Norvasc, and sales of the

Pfizer plots new strategies Local site leader Brusselmans says ...  -  May 22, 2007
Kalamazoo Gazette,Patent protection was lost on blood-pressure-medication Norvasc in March and on blockbuster antidepressant Zoloft in June 2006. Zoloft accounted for about

Pfizer CFO, R&D Chief Step Down in Shakeup  -  May 21, 2007
Smartmoney.comBut it also cut its 2007 forecast, citing an early loss of a patent for Norvasc, its strong-selling high-blood-pressure medication.

Philippines Challenges Pfizer Patent  -  May 8, 2007
Forbes,A petition was filed Tuesday to cancel Pfizer's Philippine patent on the anti-hypertension drug Norvasc after a US court invalidated the company's rights

Newly Diagnosed Patients Do Not Receive Drug Treatment Immediately  -  May 16, 2007
eMaxHealth.com,...of primary care physicians (PCPs) and 81% of cardiologists consider this benefit a reason for choosing AstraZeneca's Toprol XL over Pfizer's Norvasc.

Pre-Market Snapshot: Futures Point To Slightly Lower Open  -  May 24, 2007
Seeking Alpha,Analysts were calling for a higher $0.55/share, but the company said analyst estimates included revenue from Mylan's generic copy of Pfizer's Norvasc

Pfizer shakes up top staff  -  May 21, 2007
Asbury Park Press,Revenue this year will be $1.2 billion less than Pfizer projected after an adverse court ruling accelerated generic competition to Norvasc and sales of the

Prescription Drug Makers Increasingly Develop Combination Pills  -  May 2, 2007
Medical News Today (press release),For example, Pfizer's combination drug Caduet combines the blood pressure drug Norvasc and the cholesterol drug Lipitor. The patent for Norvasc,

Generic Form of Ambien Sleep Medication Now Available  -  May 11, 2007
Web Services Journal,This year, the patent expired on Norvasc®, prescribed for hypertension. In the upcoming year, patents are also set to expire on other widely used brand name

Two (or more) for one with prescription drugs  -  Apr 30, 2007
Los Angeles Times,Then, the Woodland, Ohio, resident heard a TV ad for Caduet, which combines the blood-pressure-lowering drug Norvasc with the cholesterol-reducing medicine

Chocolate lowers blood pressure  -  May 2, 2007
Daily Press,10, 2004) found the popular medications Norvasc (amlopidine) and Vasotec (enalapril) lowered systolic pressure by 5 points and diastolic by about 2.5 points

International market boosts Dr Reddy's revenue  -  May 23, 2007
In-PharmaTechnologist.com,Meanwhile, Dr Reddy's already makes generics of Bayer's Cipro (ciprofloxacin) and Merck's Zocar (simvastatin) and is likely to go after Pfizer's Norvasc

For Now, Mylan Remains Sole Generic Norvasc Seller  -  Apr 23, 2007
Patent Baristas,Mylan launched its generic version of Norvasc last month saying it is entitled to 180 days as the sole generic Norvasc seller and has been seeking a

Teva in fight over blood pressure drug  -  Apr 24, 2007
Jerusalem Post,Apotex is demanding a court order that the FDA immediately give it approval to sell generic Norvasc. It said Mylan shouldn't be selling the drug because it

Pfizer Earnings Fall on Drop in Norvasc, Zoloft Sales (Update5)  -  Apr 20, 2007
BloombergRevenue this year will be $1.2 billion less than Pfizer projected after an adverse court ruling accelerated generic competition to Norvasc, and sales of the

Pfizer Earnings Fall on Drop in Norvasc, Zoloft Sales (Update3)  -  Apr 20, 2007
BloombergPfizer said its revenue this year will drop $1.2 billion lower than projected because of sooner-than-expected generic competition to Norvasc and

Pfizer Lowers 2007 Outlook on Norvasc  -  Apr 20, 2007
Forbes,In late March, an appeals court invalidated Pfizer's patent for Norvasc, allowing drug maker Mylan Laboratories Inc. (nyse: MYL - news - people ) to begin

Pfizer Lowers 2007 Outlook on Norvasc  -  Apr 20, 2007
Houston Chronicle,In late March, an appeals court invalidated Pfizer's patent for Norvasc, allowing drug maker Mylan Laboratories Inc. to begin selling a generic version of

Lowers forecast in wake of early loss of Norvasc patent  -  Apr 20, 2007
MarketWatch2 product, the hypertension medication Norvasc, had sales of $1.1 billion, down 10% from the 2006 period. Pfizer's third best-seller, the pain reliever

Pfizer Earnings Fall on Drop in Norvasc, Zoloft Sales (Update2)  -  Apr 20, 2007
BloombergUS sales of the antidepressant Zoloft and the blood pressure pill Norvasc fell because of cheaper generic competition. Chief Executive Officer Jeffrey

Glaxo First-Quarter Profit Was Little Changed on Lower Sales  -  Apr 25, 2007
BloombergPfizer Inc., the world's largest drugmaker, is also facing generic competition to best-sellers such as the Norvasc blood pressure treatment.

Pfizer profits fall following Norvasc decision  -  Apr 20, 2007
MSNBCIn late March, an appeals court invalidated Pfizer's patent for Norvasc, a treatment for hypertension, allowing generic drug maker Mylan Laboratories to

Pfizer Income Falls on Decline in US Sales of Norvasc, Zoloft  -  Apr 20, 2007
BloombergRevenue rose 6 percent to $12.5 billion as US sales of the antidepressant Zocor and the blood pressure pill Norvasc fell because of cheaper generic

FDA Backs Mylan on Generic Norvasc  -  Apr 19, 2007
Forbes,Last month, the US Court of Appeals for the Federal Circuit reversed a decision in which privately held generic drug maker Apotex claimed Pfizer's Norvasc

Ranbaxy fights Pfizer on generic drugs but wants strong home law ...  -  Apr 25, 2007
Down to Earth (subscription),At the crux of the dispute is Pfizer’s designs on a patent extension by combining Lipitor with another drug: Norvasc. Ranbaxy senses a weakness in Pfizer’s

FDA OKs Mylan's generic Norvasc  -  Apr 19, 2007
United Press InternationalPITTSBURGH April 19 (UPI) -- Mylan said Thursday the US Food and Drug Administration confirmed its drug as the only approved generic of Pfizer's Norvasc.

UPDATE 1-US decides against additional Norvasc generics  -  Apr 18, 2007
ReutersMylan launched its generic version of Norvasc last month. The generic drugmaker says it is entitled to 180 days as the lone generic Norvasc seller and has

Dark chocolate lowers pressure only slightly  -  Apr 23, 2007
Jackson Clarion Ledger,A study in the Journal of the American Medical Association found the popular medications Norvasc and Vasotec lowered systolic pressure by 5 points and

Mylan intensifies pressure on Norvasc copycat makers  -  Apr 11, 2007
Daily News & Analysis,Consequently, Mylan, which launched the generic for Norvasc, received 180-day “exclusivity� from USFDA in March, following a court invalidating Pfizer’s

Pfizer and Mylan Fight to Defend Norvasc Against Generics  -  Apr 9, 2007
Seeking Alpha,Aaron F. Barkoff submits: A dozen companies have submitted letters in response to FDA's March 29 request for "comments from interested parties" on Norvasc

Pfizer 1st-Quarter Profit Falls 17.5 Percent on Charges; Outlook ...  -  Apr 20, 2007
CanadianBusiness.com,In late March, a federal appeals court invalidated Pfizer's patent for Norvasc, allowing Mylan Laboratories Inc. to begin selling a generic version.

Analysis: Pfizer solid despite earns dip  -  Apr 20, 2007
United Press InternationalGoldman Sachs analyst James Kelly said, despite the Norvasc surprise, the sound first-quarter numbers could help boost investor confidence in the stock.

Pfizer 1st-quarter profit falls 17.5 percent on charges; outlook ...  -  Apr 20, 2007
Boston Herald,In late March, a federal appeals court invalidated Pfizer’s patent for Norvasc, allowing Mylan Laboratories Inc. to begin selling a generic version.

Pfizer 1st-quarter profit falls 17.5 percent on charges; outlook ...  -  Apr 20, 2007
International Herald Tribune,Generic Norvasc sales started on March 23, thereby cutting into Pfizer's last week of sales in the first quarter. Norvasc sales dropped 10 percent to $1.07

Pfizer 1Q Profit Falls 17.5 Percent  -  Apr 20, 2007
Forbes,Generic Norvasc sales began on March 23, therefore cutting into Pfizer's sales in last week of the first quarter. Pfizer's Norvasc sales dropped 10 percent

Pfizer 1Q Profit Falls 18 Percent  -  Apr 20, 2007
Forbes,Pfizer's Norvasc sales dropped 10 percent to $1.07 billion in the first quarter. The company had hoped to retain patent protection on the drug until

Charges Drag Pfizer Q1 Profit Down 18%; Adj. Profit Up 10%; Cuts ...  -  Apr 20, 2007
Trading Markets,Norvasc sales decreased 10% to $1.06 billion, sales of Zoloft plunged 81% to $146 million and Zithromax dropped 49% to $131 million.

Pfizer 1Q profit falls 17.5 percent  -  Apr 20, 2007
Euro2day,In late March, a federal appeals court invalidated Pfizer''s patent for Norvasc, allowing Mylan Laboratories Inc. to begin selling a generic version.

Pfizer 1Q Profit Falls 17.5 Percent  -  Apr 20, 2007
Forbes,Pfizer's Norvasc sales dropped 10 percent to $1.07 billion in the quarter. Favorable exchange rates, which make Pfizer products cheaper overseas,

Pfizer 1Q profit falls 17.5 percent  -  Apr 20, 2007
Houston Chronicle,In late March, a federal appeals court invalidated Pfizer's patent for Norvasc, allowing Mylan Laboratories Inc. to begin selling a generic version six

Mylan set for exclusive generic Norvasc into April  -  Mar 27, 2007
ReutersN: Quote, Profile , Research) Norvasc blood-pressure drug until at least April 13 after a US court enjoined the Food and Drug Administration from approving

Pfizer 1Q profit falls 17.5 percent  -  Apr 20, 2007
Euro2day,In late March, a federal appeals court invalidated Pfizer''s patent for Norvasc, allowing Mylan Laboratories Inc. to begin selling a generic version six

Mylan set for exclusive generic Norvasc into April  -  Mar 27, 2007
ReutersN: Quote, Profile, Research) Norvasc blood-pressure drug until at least April 13 after a US court enjoined the Food and Drug Administration from approving

Mylan Can Breathe Easy on Norvasc Until April 13  -  Mar 27, 2007
Seeking Alpha,Mylan launched its generic Norvasc last week and, with the exception of Pfizer's authorized generic, currently has the only generic Norvasc on the market.

US court stops new Norvasc generics  -  Mar 28, 2007
Pharma Times (subscription),Mylan Laboratories says that a US court has blocked the Food and Drug Administration from approving competing generic versions of Pfizer's Norvasc until

Pfizer 1Q profit falls 17.5 percent  -  Apr 20, 2007
Euro2day,Generic Norvasc sales started on March 23, thereby cutting into Pfizer''s last week of sales in the first quarter. Norvasc sales dropped 10 percent to $1.07

Pfizer 1Q profit falls 18 percent  -  Apr 20, 2007
White Rock Reviewer,Pfizer‘s Norvasc sales dropped 10 percent to $1.07 billion in the first quarter. The company had hoped to retain patent protection on the drug until

Pfizer sees 17 percent profit decline  -  Apr 20, 2007
Trenton Times,In late March, a federal appeals court invalidated Pfizer's patent for Norvasc, allowing Mylan Laboratories to begin selling a generic ver sion six months

Pfizer cuts forecast, as generics cut deeper  -  Apr 21, 2007
ReutersN: Quote, Profile, Research) cut its 2007 forecast on Friday on plunging demand for hypertension drug Norvasc in the face of generic competition and warned

Pfizer Delivers Solid First-Quarter 2007 Results, Updates Full ...  -  Apr 20, 2007
PharmaLive.com (press release),...“And with regard to our near-term performance, apart from the impact of losing US exclusivity for Norvasc six months earlier than expected and the

Pfizer Delivers Solid First-Quarter 2007 Results, Updates Full ...  -  Apr 20, 2007
Genetic Engineering News (press release),..."And with regard to our near-term performance, apart from the impact of losing US exclusivity for Norvasc six months earlier than expected and the

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional